View Older Stories View More Recent Stories

Oct 17, 2017 07:00AM Gemini Therapeutics Announces $42.5 Million Series A Financing to Develop Precision Therapeutics in Ophthalmology and Rare Genetic Diseases
Oct 11, 2017 08:38AM PlacementTracker Publishes Q3 2017 Private Placement Market League Tables
Oct 5, 2017 03:48PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 2, 2017 04:02PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 2, 2017 09:00AM Brookline Capital Markets Announces a Major Expansion of Its Healthcare Investment Banking Services, Equity Research Department and Team
Sep 28, 2017 05:25PM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 27, 2017 04:00AM KaNDy Therapeutics Launched to Advance a Breakthrough Treatment in Women's Health
Sep 21, 2017 07:39AM ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare
Sep 20, 2017 08:00AM Inspire Medical Systems' Inspire Therapy for Reducing Obstructive Sleep Apnea Demonstrates Long-term Safety and Sustained Benefit Following 5 Years of Treatment
Sep 18, 2017 06:00AM Sonendo® Announces Growth Investment from General Atlantic
Sep 7, 2017 02:21PM Form SC 13D SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Aug 23, 2017 05:18PM Form SC 13D/A Clementia Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Aug 23, 2017 10:15AM Form SC 13D/A Roka BioScience, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 22, 2017 08:00AM Avitide, Inc., Receives ISO 9001:2015 Certification for Its Affinity Resin Manufacturing Facility
Aug 15, 2017 05:07PM Form SC 13D/A SELECTA BIOSCIENCES INC Filed by: ORBIMED ADVISORS LLC
Aug 14, 2017 04:44PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 11, 2017 01:37PM Form SC 13D Clementia Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Aug 9, 2017 12:11PM Form SC 13D/A ViewRay, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 8, 2017 04:05PM Natera Reports Second Quarter 2017 Financial Results
Aug 3, 2017 02:17PM Form SC 13D ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Aug 1, 2017 07:30AM  Intellia Therapeutics Announces Second Quarter 2017 Financial Results
Jul 27, 2017 05:30AM Cyrus Biotechnology Announces $8M Financing to Expand Computational Drug Discovery Software Platform
Jul 25, 2017 06:30AM Alpine Immune Sciences, Inc. Completes Merger with Nivalis Therapeutics, Inc.
Jul 25, 2017 05:46AM Intellia Therapeutics (NTLA) Appoints Moncef Slaoui and Frank Verweil to Board
Jul 24, 2017 06:30PM Intellia Therapeutics Names Moncef Slaoui, Ph.D. and Frank Verwiel, M.D. to Its Board of Directors and Establishes a Science and Technology Committee
Jul 6, 2017 04:31PM Form SC 13D/A OTONOMY, INC. Filed by: ORBIMED ADVISORS LLC
Jun 29, 2017 04:03PM Sangamo Biosciences (SGMO) Names Roger Jeffs & Joseph Zakrzewski to Board
Jun 29, 2017 04:01PM Sangamo Therapeutics Appoints Roger Jeffs, Ph.D. and Joseph S. Zakrzewski to its Board of Directors
Jun 26, 2017 08:01AM Nabriva (NBRV) Appoints Carrie Bourdow and Colin Broom to the Board
Jun 26, 2017 08:00AM Nabriva Therapeutics Appoints Carrie Bourdow and Colin Broom to the Board
Jun 21, 2017 04:17PM Form SC 13D/A Ascendis Pharma A/S Filed by: ORBIMED ADVISORS LLC
Jun 21, 2017 08:00AM Avitide, Inc., Raises Series E Financing from Sands Capital Ventures with Broad Participation from Early Investors
Jun 15, 2017 05:08PM Form SC 13G CTI BIOPHARMA CORP Filed by: ORBIMED ADVISORS LLC
Jun 5, 2017 09:00AM Inspire Medical Systems Announces FDA Approval of Inspire 3028 Neurostimulator for the Treatment of Obstructive Sleep Apnea
Jun 2, 2017 10:00AM OxOnc Announces that Co-development Partner Has Received Approval in Japan and Taiwan for Crizotinib (Xalkori®) as a First-line Treatment for Patients with ROS1-Positive Non-Small Cell Lung Cancer
May 30, 2017 04:44PM OrbiMed Advisors Raises Stake in XTENT, Inc. (XTNT) to 9.9%
May 30, 2017 04:40PM Form SC 13D Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
May 23, 2017 07:01AM TP Therapeutics Closes $45M Series C Financing
May 15, 2017 04:38PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 12, 2017 07:30AM Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners
May 8, 2017 02:00PM Form SC 13D Verona Pharma plc Filed by: ORBIMED ADVISORS LLC
May 1, 2017 04:01PM Nivalis Therapeutics Reports First Quarter 2017 Financial Results
Apr 28, 2017 03:32PM Form SC 13D/A SteadyMed Ltd. Filed by: ORBIMED ADVISORS LLC
Apr 27, 2017 04:59PM Form 4 SteadyMed Ltd. For: Apr 25 Filed by: ORBIMED ADVISORS LLC
Apr 27, 2017 08:00AM Avedro Announces $42 Million in Funding to Support Commercial Expansion and Pipeline Development
Apr 25, 2017 08:00AM DiaMedica Announces Dr. Nancy Chang to its Strategic Advisory Board
Apr 18, 2017 04:06PM Nivalis Therapeutics (NVLS) to Merge with Alpine Immune Sciences in All-Stock Deal
Apr 18, 2017 04:05PM Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc. Agree to Combine
Apr 12, 2017 09:19AM Unilife Corp. (UNIS) Files Chapter 11 Bankruptcy in Delaware
Apr 12, 2017 09:17AM Unilife Files for Chapter 11 Protection
View More Recent Stories View Older Stories